93 related articles for article (PubMed ID: 30506430)
1. IL-39 acts as a friend to pancreatic cancer.
Manning AA; Zhao L; Zhu Z; Xiao H; Redington CG; Ding VA; Stewart-Hester T; Bai Q; Dunlap J; Wakefield MR; Fang Y
Med Oncol; 2018 Dec; 36(1):12. PubMed ID: 30506430
[TBL] [Abstract][Full Text] [Related]
2. IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer.
Fang Y; Zhao L; Xiao H; Cook KM; Bai Q; Herrick EJ; Chen X; Qin C; Zhu Z; Wakefield MR; Nicholl MB
Med Oncol; 2017 Feb; 34(2):23. PubMed ID: 28058630
[TBL] [Abstract][Full Text] [Related]
3. IL-29 Exhibits Anti-Tumor Effect on Pan-48 Pancreatic Cancer Cells by Up-regulation of P21 and Bax.
Balabanov D; Zhao L; Zhu Z; Hunzeker ZE; Tonner HM; Ding VA; Wakefield MR; Bai Q; Fang Y
Anticancer Res; 2019 Jul; 39(7):3493-3498. PubMed ID: 31262873
[TBL] [Abstract][Full Text] [Related]
4. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
Ha JL; Kaser E; Guan T; Mayberry TG; Smith LA; D'mello K; Bai Q; Wakefield MR; Dong L; Fang Y
Med Oncol; 2024 Jan; 41(3):65. PubMed ID: 38281234
[TBL] [Abstract][Full Text] [Related]
5. The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer.
Chen X; Lee HY; Tang TT; Qin C; Prissel SA; Nelson CJ; Smith LA; Xiao H; Bai Q; Nicholl MB; Wakefield MR; Fang Y
Anticancer Res; 2023 May; 43(5):1885-1890. PubMed ID: 37097692
[TBL] [Abstract][Full Text] [Related]
6. Peptide tyrosine-tyrosine combined with its receptors exhibits an anti-cancer potential in pancreatic cancer MiaPaCa-2 cell.
Li H; Wang Z; Dong L; Jiang J; Xu X; Zhou L; Wan Y
Chin Med J (Engl); 2014; 127(24):4235-42. PubMed ID: 25533827
[TBL] [Abstract][Full Text] [Related]
7. IL-39 Reduces Proliferation and Promotes Apoptosis of Bladder Cancer by Altering the Activity of Cyclin E and Fas.
Xiao H; Alisic H; Reiman BT; Deng Z; Zhu Z; Givens NT; Bai Q; Tait A; Wakefield MR; Fang Y
Anticancer Res; 2021 May; 41(5):2239-2245. PubMed ID: 33952450
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Asparagus Extract on Pancreatic Cancer: An Intriguing Surprise.
Xiao H; Deng Z; Hough JT; Chen X; Zhu Z; Lee J; Dominguez A; Shi T; Schmidt J; Bai Q; Wakefield MR; Fang Y
Anticancer Res; 2022 May; 42(5):2425-2432. PubMed ID: 35489758
[TBL] [Abstract][Full Text] [Related]
9. Association between interleukin‑33 and ovarian cancer.
Liu X; Hansen DM; Timko NJ; Zhu Z; Ames A; Qin C; Nicholl MB; Bai Q; Chen X; Wakefield MR; West G; Fang Y
Oncol Rep; 2019 Feb; 41(2):1045-1050. PubMed ID: 30535474
[TBL] [Abstract][Full Text] [Related]
10. IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor.
Nicholl MB; Ledgewood CL; Chen X; Bai Q; Qin C; Cook KM; Herrick EJ; Diaz-Arias A; Moore BJ; Fang Y
Cytokine; 2014 Dec; 70(2):126-33. PubMed ID: 25073578
[TBL] [Abstract][Full Text] [Related]
11. IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL.
Fang Y; Chen X; Bai Q; Qin C; Mohamud AO; Zhu Z; Ball TW; Ruth CM; Newcomer DR; Herrick EJ; Nicholl MB
J Surg Oncol; 2015 Jun; 111(8):969-74. PubMed ID: 25988864
[TBL] [Abstract][Full Text] [Related]
12. IL-32α has differential effects on proliferation and apoptosis of human melanoma cell lines.
Nicholl MB; Chen X; Qin C; Bai Q; Zhu Z; Davis MR; Fang Y
J Surg Oncol; 2016 Mar; 113(4):364-9. PubMed ID: 27100023
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells.
Miyamoto Y; Hosotani R; Doi R; Wada M; Ida J; Tsuji S; Kawaguchi M; Nakajima S; Kobayashi H; Masui T; Imamura M
Anticancer Res; 2001; 21(4A):2449-56. PubMed ID: 11724306
[TBL] [Abstract][Full Text] [Related]
15. Artichoke as a melanoma growth inhibitor.
Mathew AM; Deng Z; Nelson CJ; Mayberry TG; Bai Q; Lequio M; Fajardo E; Xiao H; Wakefield MR; Fang Y
Med Oncol; 2023 Aug; 40(9):262. PubMed ID: 37544953
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic stellate cells: partners in crime with pancreatic cancer cells.
Vonlaufen A; Joshi S; Qu C; Phillips PA; Xu Z; Parker NR; Toi CS; Pirola RC; Wilson JS; Goldstein D; Apte MV
Cancer Res; 2008 Apr; 68(7):2085-93. PubMed ID: 18381413
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
[TBL] [Abstract][Full Text] [Related]
18. Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells.
Kuwada Y; Sasaki T; Morinaka K; Kitadai Y; Mukaida N; Chayama K
Int J Oncol; 2003 Apr; 22(4):765-71. PubMed ID: 12632066
[TBL] [Abstract][Full Text] [Related]
19. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
[TBL] [Abstract][Full Text] [Related]
20. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
